Cardiovascular Diseases

Publications

click to view chapters and sections

Disease Control Priorities in Developing Countries (2nd Edition)

1. 33. Cardiovascular Disease
   1. Burden of Disease
   2. Conclusions: Pitfalls and Promises
   3. Cost-Effectiveness of Interventions
   4. Epidemiology of CVD
   5. Research and Development
2. 62. Control and Eradication
3. 15. Cost–Effectiveness Analysis for Priority Setting
   1. Cost-Effectiveness and Population Impact
4. 36. Diseases of the Kidney and the Urinary System
   1. Causes of Diseases of the Kidney and Urinary System
   2. Conclusions: Promises and Pitfalls
   3. Implementation of Control Strategies: Lessons of Experience
5. 7. Economic Approaches to Valuing Global Health Research
   1. The Value of Health Research
6. 14. Ethical Issues in Resource Allocation, Research, and New Product Development
7. 2. Intervention Cost–Effectiveness: Overview of Main Messages
   1. Annex 2.A: Intervention Categories and Pertinent Policy Instruments
8. 1. Investing in Health
   1. Noncommunicable Disease and Injury
9. 32. Neurological Disorders
   1. Acknowledgments
   2. Cost-Effectiveness of Interventions in Developing Countries
   3. Missed Opportunities
   4. Parkinson's Disease
   5. Recommendations
   6. Research and Development Agenda
   7. Stroke
10. 44. Prevention of Chronic Disease by Means of Diet and Lifestyle Changes
    1. Conclusions
    2. Cost-Effectiveness of Interventions
11. 4. Priorities for Global Research and Development of Interventions
12. 5. Science and Technology for Disease Control: Past, Present, and Future
13. 45. The Growing Burden of Risk from High Blood Pressure, Cholesterol, and Bodyweight
    1. Burden of the Disease, Condition, or Risk Factor
    2. Conclusions
    3. Cost-Effectiveness of Interventions
    4. Economic Benefits of Intervention
    5. Epidemiology
    6. Interventions
    7. Research and Development Agenda
14. 46. Tobacco Addiction
    1. Health Consequences of Smoking
15. 22. Tropical Diseases Targeted for Elimination: Chagas Disease, Lymphatic Filariasis, Onchocerciasis, and Leprosy
    1. Disease Characteristics and Transmission

Global Burden of Disease and Risk Factors

1. 4. Comparative Quantification of Mortality and Burden of Disease Attributable to Selected Risk Factors
   1. Burden of Disease Attributable to Multiple Risk Factors
   2. Directions for Future Research
   3. Discussion
   4. Joint Effects of Multiple Risk Factors
   5. Risk Factor Selection
2. 1. Measuring the Global Burden of Disease and Risk Factors, 1990—2001
3. 3. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001
   1. Burden of Disability and Poor Health in 2001
   2. Discussion and Conclusions

Priorities in Health

1. 5. Cost–Effective Strategies for Noncommunicable Diseases, Risk Factors, and Behaviors
   1. Alcohol Abuse
   2. Cardiovascular Disease, Diabetes, High Blood Pressure, Cholesterol, and Bodyweight
   3. Conclusion
   4. Mental Health
   5. Unintentional Injuries
2. 7. Pillars of the Health System

Chapter Presentations

Chapter 02. Intervention Cost-Effectiveness: Overview of Main Messages

1. Neglected Low-Cost Opportunities in Sub-Saharan Africa: Cardiovascular Disease
2. Neglected Low-Cost Opportunities in South Asia: Cardiovascular Disease
3. Cost-effectiveness of Interventions for Cardiovascular Disease and Diabetes in Low- and Middle-Income Countries

Chapter 45. The Growing Burden of Risk from High Blood Pressure, Cholesterol, and Bodyweight

1. Cost-effectiveness of Interventions for Cardiovascular Disease in Latin America and the Caribbean*
2. Global Cardiovascular Disease Burden Due to High Blood Pressure, Cholesterol, and Overweight
3. Cost-effectiveness of Interventions for Cardiovascular Disease in Africa*
4. Cost-effectiveness of Interventions for Cardiovascular Disease in Southeast Asia*
5. Cost-effectiveness of Interventions for Cardiovascular Disease in the Western Pacific*
6. Estimates of Cost-effectiveness of a Polypill for Cardiovascular Disease, By Region
7. Estimates of Cost-effectiveness of a Polypill for Cardiovascular Disease in India